Putting the brakes on the gene drive

July 11, 2018, Cardiff University
Putting the brakes on the gene drive
Credit: Cardiff University

A biological switch that could potentially regulate gene drive technology has been created by researchers from Cardiff University.

The , a cheap and non-toxic amino acid called BOC, could switch proteins 'on' and 'off' in any species and offers promise in a whole host of fields, from pest control to regenerative medicine.

The team of researchers, which also includes scientists from the University of Bath, believe the switch could be particularly useful in an emerging technology known as a gene drive.

Gene drives are methods in which the of a species can be altered in such a way that it ensures all offspring in sexually reproducing species inherit a particular genetic segment. This technology would override the 50% chance that offspring would have of inheriting a particular trait.

Characteristics that are given by a gene drive can spread rapidly through a population regardless of whether or not they are advantageous.

They might, for example, make livestock more resilient to disease, enhance the nutritional value of crops or eliminate the mosquitoes that transmit infectious diseases like malaria.

However, multiple challenges must be met before gene drive usage is likely to be authorised. Once initiated, they are difficult or impossible to control and may work over wider areas than desired, for example straying across international borders. They may have unintended environmental consequences or give rise to resistance.

The researchers believe the non-physiological amino acid, BOC, could completely change the gene drive process so that the altered are only guaranteed to be passed on if the organism has been fed the amino acid. Without BOC the gene drive is switched off and all offspring would be become subject to the natural laws of inheritance, returning the populations to its more diverse selection of possible traits.

In their study, which has been published in the journal Scientific Reports, the team successfully demonstrated the technology by using the amino acid BOC to turn a specific protein 'on' and 'off' in early-stage mice embryos.

Co-author of the study Dr. Yu-Hsuan Tsai from the School of Chemistry said: "Although BOC provides an attractive and promising means to control editing, we are now working to address remaining challenges and iron out wrinkles in the system."

Professor Tony Perry, from the University of Bath, said: "Our switch is a way of controlling the expression of any protein via genetic code expansion.

What sets our work apart is the potential for this as an environmentally friendly switch across large distances, which no previous method really enables. For example you can imagine controlling activity in livestock herds by adding or removing BOC from feedstuffs as required.

Gene editing has enormous potential across biological science, from biomedicine to food security, in insects, plants and animals."

More information: Toru Suzuki et al. Switchable genome editing via genetic code expansion, Scientific Reports (2018). DOI: 10.1038/s41598-018-28178-3

Related Stories

Recommended for you

Analytical tool predicts genes that can cause disease by producing altered proteins

July 19, 2018
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international ...

Childhood stress leaves lasting mark on genes

July 18, 2018
Kids who experience severe stress are more likely to develop a host of physical and mental health problems by the time they reach adulthood, including anxiety, depression and mood disorders. But how does early life stress ...

Study shows DNA methylation related to liver disease among obese patients

July 18, 2018
DNA methylation is a molecular process that helps enable our bodies to repair themselves, fight infection, get rid of environmental toxins, and even to think. But sometimes this process goes awry.

Protein found to be key component in irregularly excited brain cells

July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor ...

World's largest study on allergic rhinitis reveals new risk genes

July 17, 2018
An international team of scientists led by Helmholtz Zentrum München and University of Copenhagen has presented the largest study so far on allergic rhinitis in the journal Nature Genetics. The data of nearly 900,000 participants ...

New platform poised to be next generation of genetic medicines

July 16, 2018
A City of Hope scientist has discovered a gene-editing technology that could efficiently and accurately correct the genetic defects that underlie certain diseases, positioning the new tool as the basis for the next generation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.